Pharmaceutical - Antibiotics and Infectious diseases, Tropical diseases


Popular Filters

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products


UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

New executive director of the Global Fund outlines ambitious agenda


Mark Dybul yesterday took charge as executive director of the Global Fund to Fight AIDS, Tuberculosis…

Anti-viralsAntibiotics and Infectious diseasesFinancialManagementPharmaceuticalTropical diseases

Regulatory briefs: Amitiza in Japan; Dificid in Canada; Eurartesim roll-out


Sucampo Pharmaceuticals (Nasdaq: SCMP) and Abbott Labs (NYSE: ABT) have received approval from the Ministry…

Abbott LaboratoriesAmitizaAntibiotics and Infectious diseasesAsia-PacificDificidEurartesimGastro-intestinalsMarkets & MarketingNorth AmericaOptimer PharmaceuticalsPharmaceuticalRegulationSigma-TauSucampoTropical diseases

GlaxoSmithKline partners with BARDA to develop new class of antibiotic; amends deal with Anacor


The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority…

Anacor PharmaceuticalAntibiotics and Infectious diseasesFinancialGlaxoSmithKlineLicensingPharmaceuticalResearchTropical diseases

Back to top